Hospice Guidance and Actions - CMS regulations and guidance support Hospice Agencies taking appropriate action to address potential and confirmed COVID cases and mitigate transmission including screening, treatment, and transfer to higher level care (when appropriate). This guidance applies to both Medicare and Medicaid providers.
Hospice Agencies should regularly monitor the CDC website (see links below) for information and contact their local health department when needed (https://www.cdc.gov/coronavirus/2019- ncov/whats-new-all.html). Also, hospice agencies should be monitoring the health status of patients, residents, visitors, volunteers, and staff under their care setting for signs or symptoms COVID-19. Per CDC, prompt detection, triage and isolation of potentially infectious patients are essential to prevent unnecessary exposures among patients, healthcare personnel, volunteers and visitors at the facility.
How should providers screen volunteers, visitors and patients for COVID-19 in a Hospice that provides short-term inpatient care directly or in an inpatient unit of another facility? Hospices should identify volunteers, visitors and patients at risk for having COVID-19 infection before or immediately upon arrival to the inpatient unit. They should be asked about the following:
1. International travel within the last 14 days.
2. Signs or symptoms of a respiratory infection, such as a fever, cough, and shortness of breath.
3. In the last 14 days, have you had contact with someone with or under investigation for COVID19, or are ill with respiratory illness.
4. Residing in a community where community-based spread of COVID-19 is occurring.
Please complete the following question: